Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
3.3M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
5.04K
-
Shares change
-
+5.04K
-
Total reported value, excl. options
-
$15.4K
-
Value change
-
+$15.4K
-
Number of buys
-
6
-
Price
-
$3.02
Significant Holders of Aptevo Therapeutics Inc. - Common Stock (APVO) as of Q2 2025
6 filings reported holding APVO - Aptevo Therapeutics Inc. - Common Stock as of Q2 2025.
Aptevo Therapeutics Inc. - Common Stock (APVO) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.04K shares
of 3.3M outstanding shares and own 0.15% of the company stock.
Largest 6 shareholders include OSAIC HOLDINGS, INC. (3.25K shares), Tower Research Capital LLC (TRC) (1.19K shares), SBI Securities Co., Ltd. (588 shares), BANK OF AMERICA CORP /DE/ (3 shares), BlackRock, Inc. (1 shares), and DANSKE BANK A/S (1 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.